image
image
image
PARTNERS IN RESEARCH: CNDR || IOA || UDALL || Penn ADC
image

News From the Lab

Check back frequently for the latest information on research findings in neurodegenerative diseases from CNDR and its partner programs at Penn. Click on the 'get more information' links to connect with the full press releases and news.

News from the CNDR Research Lab

March 13, 2012

CNDR Study Shows Potential Alzheimer's Disease Drug Slows Damage and Symptoms in Animal Model. More information and interview...

October 6, 2011

Research from CNDR and Penn Udall Center Find Abnormal Parkinson's Disease Protein Induces Degeneration in Healthy Nerve Cells. More information...

June 27, 2011

Virginia Lee, PhD, and colleagues at CNDR question the role of A-Beta molecules in Alzheimer's pathology. More information...

May 6, 2011

CNDR will partner with Johnson & Johnson Pharmaceutical Research and Development, L.L.C., (J&JPRD) to develop algorithms that can identify changes in biomarkers related to disease diagnosis and for monitoring disease progression. More information...

January 4, 2011

Research from a team at CNDR led by Virginia Lee, PhD, shows that a malfunctioning gene associated with ALS leads to nerve-cell death in mice. More information...

November 29, 2010

 

Alice Chen-Plotkin, MD, Leslie M. Shaw, PhD, Vivianna M. Van Deerlin, MD, PhD, Virginia M.-Y. Lee, PhD, MBA and John Q. Trojanowski, MD, PhD, and their colleagues in the Penn Udall Center for Parkinson's Research, have developed the first blood-based biomarker test to predict cognitive decline in Parkinson’s disease (PD). More information...

October, 2010

 

A new Penn CNDR study, published this week in the Journal of Neuroscience, has found and tested in an animal model of Alzheimer’s disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning. More information...

August 9, 2010

 

A new study, conducted by team of researchers using research from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Biomarker Core group, which is co-directed by John Q. Trojanowski, MD, PhD, Co-director, Center for Neurodegenerative Disease Research and Leslie M. Shaw, PhD, provides additional evidence that a biomarker test can be used to reliably determine an Alzheimer’s disease diagnosis. More information...

August 10, 2009

Alzheimer's disease
Alex Crowe, Research Specialist; Kurt R. Brunden, PhD, Director of Drug Discovery at Penn’s Center for Neurodegenerative Disease Research (CNDR); Virginia M.-Y. Lee, PhD, and John Q. Trojanowski,CNDR Co-Directors, and their colleagues at the National Institutes of Health (NIH) Chemical Genomics Center (NCGC) have discovered a new class of compounds for potentional Alzheimer's disease drug. More information...

April 8, 2009

Alzheimer's disease

Dr. Jerry Schellenberg Receives $18.3 Million National Institute on Aging Grant to Lead Alzheimer’s Disease Genetics Consortium Study. More information...

March 16, 2009

Alzheimer's disease

Penn Medicine Pathologists Pioneer Biomarker Test to Diagnose or Rule Out Alzheimer’s Disease. Get more information...

June 16, 2008

ALS/Lou Gehrig's Disease

Penn researchers find Lou Gehrig’s Disease protein throughout brain, suggesting effects beyond motor neurons. Get more information...

April 7, 2008

ALS/Lou Gehrig's Disease

More Genes for Lou Gehrig’s Disease Identified, According to Penn Researchers. Get more information...

Penn News in Neurodegenerative Disease Research

back to News